Literature DB >> 1556002

Interaction of the tumor inhibitor IKP-104, a 4(1H)-pyridinone derivative, with microtubule proteins.

F Mizuhashi1, K Murata, T Kitagaki, I Tomita.   

Abstract

The effects of a mitotic arrestant, IKP-104, which has an antitumor activity, on the in vitro polymerization and depolymerization of rat brain microtubules were investigated. IKP-104 inhibited microtubule polymerization at concentrations greater than 0.71 x 10(-6) M, and its IC50 value was determined to be 1.31 x 10(-6) M by probit analysis. Fifty-two percent of pre-polymerized microtubules depolymerized at 1.31 x 10(-6) M IKP-104. Electron micrographs of microtubules taken immediately after treatment with 1 x 10(-3) M IKP-104 revealed a fraying of microtubule ends into elongated coil-like filaments, which were composed of 2 or 3 protofilaments. When microtubule protein treated with 1 x 10(-3) M IKP-104 was cleaved by trypsin, fragments of 41, 36, 34, 23, 21, 19 and 16 kilodaltons (kDa) derived from alpha-tubulin were produced. In particular, the 19, 23, and 34 kDa fragments were characteristically observed in the trypsin cleavage of microtubules tested with IKP-104, and these fragments were not observed with untreated microtubules. The effects of IKP-104 on microtubule protein mentioned above were mostly similar to those of vinblastine (VLB) and we suggest that IKP-104 bound to the site or sites near "VLB-binding site or sites" of alpha-tubulin subunit, resulting in induction of conformational changes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1556002      PMCID: PMC5918791          DOI: 10.1111/j.1349-7006.1992.tb00088.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


colchicine vinblastine sulfate ‐(N‐morpholino)ethanesulfonic acid ethyleneglycol‐O, O′‐bis(β‐aminoethyl ether)‐N, N, N′,N′‐tetraacetic acid guanosine‐5′‐triphosphate phenylmethylsulfonyl fluoride 2‐nitro‐4‐car‐boxyphenyl‐N, N‐diphenyl carbamate sodium dodecyl sulfate bromophenol blue trichloroacetic acid polyvinylidene difluoride 3,3′‐diaminobenzidine 50% inhibitory concentration guanyl‐5′‐methylene diphosphonate
  26 in total

1.  Tubulin aggregation and disaggregation: mediation by two distinct vinblastine-binding sites.

Authors:  B Bhattacharyya; J Wolff
Journal:  Proc Natl Acad Sci U S A       Date:  1976-07       Impact factor: 11.205

2.  Negatively stained vinblastine aggregates.

Authors:  H P Erickson
Journal:  Ann N Y Acad Sci       Date:  1975-06-30       Impact factor: 5.691

3.  Selection of a nucleation-promoting element following chemical modification of tubulin.

Authors:  T M Sioussat; K Boekelheide
Journal:  Biochemistry       Date:  1989-05-16       Impact factor: 3.162

4.  [Microsequence analysis of proteins electroblotted from polyacrylamide gels].

Authors:  H Hirano
Journal:  Tanpakushitsu Kakusan Koso       Date:  1988-10

5.  Molecular weight analysis of oligopeptides by electrophoresis in polyacrylamide gel with sodium dodecyl sulfate.

Authors:  R T Swank; K D Munkres
Journal:  Anal Biochem       Date:  1971-02       Impact factor: 3.365

6.  Microtubule assembly in the absence of added nucleotides.

Authors:  M L Shelanski; F Gaskin; C R Cantor
Journal:  Proc Natl Acad Sci U S A       Date:  1973-03       Impact factor: 11.205

7.  Interaction of drugs with microtubule proteins.

Authors:  L Wilson; J R Bamburg; S B Mizel; L M Grisham; K M Creswell
Journal:  Fed Proc       Date:  1974-02

8.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

9.  Analysis of drug-tubulin interaction by trypsin cleavage: comparison for colchicine, podophyllotoxin, griseofulvin, vinblastine and taxol.

Authors:  F Wandosell; N Villanueva; L Serrano; J Avila
Journal:  Comp Biochem Physiol B       Date:  1986

10.  Effect of microtubule-associated proteins on the interaction of vincristine with microtubules and tubulin.

Authors:  J A Donoso; K M Haskins; R H Himes
Journal:  Cancer Res       Date:  1979-05       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.